Minimally Invasive Surgery Market

The minimally invasive surgery market is projected to reach USD 173.9 billion by 2029 from USD 79.3 billion in 2024, growing at a CAGR of 17.0% during the forecast period. Growth in the minimally invasive surgery market is mainly due to an increase in technological advancements, Growing investments and funds and patient benefits such as reduced time and quick recovery.

The minimally invasive surgery market is characterized by a moderate level of competition, with some well-established players holding a significant market share. The market is more competitive because of the increased funding for heart-related issues and the rise in technological developments brought about by higher R&D expenditures. Here are some of the key players in the minimally invasive surgery market Medtronic plc as(Ireland), Johnson & Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith & Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Company (US) are few  of the prominent companies in the minimally invasive surgery market.

To know about the assumptions considered for the study download the pdf brochure

Abbott Laboratories (US) : Abbott's structural heart business provides minimally invasive treatments for structural heart problems such as heart valve dysfunction and congenital heart abnormalities. The division's products include transcatheter heart valves, delivery systems, and other devices intended for less invasive operations than standard open-heart surgery. Abbott's minimally invasive structural cardiac procedures include the Portico valve, a transcatheter aortic valve replacement (TAVR) system.Abbott offers minimally invasive vascular treatments, including treatment for peripheral arterial disease (PAD) and coronary artery disease (CAD). The company provides a variety of catheter-based technologies, including drug-eluting stents, balloon angioplasty systems, and atherectomy devices, which are intended to restore blood flow in damaged arteries while minimising disruption to adjacent tissues. Abbott's structural heart division provides minimally invasive solutions for CAD. One of their hallmark products is the Xience drug-eluting stent.

Medtronic plc (Ireland): Medtronic designs and manufactures a wide range of minimally invasive surgical devices and tools for treatments across multiple medical specialties. These products include laparoscopic instruments, surgical staplers, energy-based devices (such as electrosurgical generators and ultrasonic dissectors), and visualization systems (such as cameras and monitors) that allow surgeons to perform precise and controlled procedures through small incisions. Medtronic is a prominent player in robotic-assisted surgery, having acquired Mazor Robotics and now offering the da Vinci Surgical System. The da Vinci System allows surgeons to do minimally invasive procedures with more precision, skill, and visualization, especially in urology, gynecology, and general surgery. The system consists of robotic arms, a console for the surgeon to manage the instruments, and high-definition 3D vision.

Johnson & Johnson (US): Ethicon, a Johnson & Johnson subsidiary, is a market leader in minimally invasive surgery solutions. Ethicon's product line includes advanced laparoscopic instruments, surgical staplers, energy-based devices (such as ultrasonic and electrocautery devices), and hemostatic agents that are used in a variety of surgical specialties, including general surgery, gynaecology, urology, and gastrointestinal surgery.J&J's biosurgery division develops novel technologies for minimally invasive procedures that promote tissue repair and reduce surgical complications. These items include surgical sealants, hemostats, and adhesion prevention treatments, which are used to improve patient outcomes and surgical efficiency in a variety of disciplines such as orthopaedics, neurology, and cardiovascular surgery.

Stryker Corporation(US):Stryker Corporation is a global leader in medical technology, providing a diverse variety of products and services in orthopaedics, neurotechnology, spine, and surgical tools. Stryker has a strong presence in the field of minimally invasive surgery (MIS), offering innovative equipment and solutions that allow surgeons to execute treatments with less tissue trauma and shorter recovery times. Stryker offers minimally invasive technologies for neurosurgery treatments such as cranial and spinal surgery. These technologies include neuroendoscopes, navigation systems, and image-guided surgery platforms that allow precise and less disruptive procedures for illnesses such as brain tumours, hydrocephalus, and spinal cord injuries.

Boston scientific Corporation(US): Boston Scientific offers minimally invasive technologies for the detection and treatment of cardiovascular diseases including as coronary artery disease, peripheral artery disease, and structural heart defects. Drug-eluting stents, balloon catheters, atherectomy devices, and transcatheter heart valves are among the products offered by the firm. They are used in percutaneous coronary interventions (PCI), peripheral vascular interventions (PVI), and transcatheter aortic valve replacement (TAVR). Boston Scientific's interventional cardiology solutions are designed to restore blood flow, improve cardiac function, and reduce the need for open heart surgery.

Related Reports:

Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), End-user, and Surgery volume - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]